Literature DB >> 6263523

The effect of urine, pyrophosphate, citrate, magnesium and glycosaminoglycans on the growth and aggregation of calcium oxalate crystals in vitro.

R L Ryall, R M Harnett, V R Marshall.   

Abstract

The effects of pyrophosphate, citrate, magnesium, heparin and chondroitin sulphate on the growth and aggregation of calcium oxalate crystals were measured at concentrations likely to be found in 1% urine. The degrees of inhibition of growth and of aggregation caused by these compounds were related to the effects of normal 1% urine on these processes. It was concluded that chondroitin sulphate is responsible for the major portion of the inhibitory effect of urine on crystal aggregation, but that the effect on crystal growth is probably due to the additive or synergistic effects of a number of urinary constituents.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6263523     DOI: 10.1016/0009-8981(81)90458-7

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  39 in total

1.  Synergism between the brushite and hydroxyapatite urinary crystallization inhibitors.

Authors:  Antonia Costa-Bauzá; Catalina Barceló; Juan Perelló; Felix Grases
Journal:  Int Urol Nephrol       Date:  2002       Impact factor: 2.370

2.  Urinary crystal surface binding substances on calcium oxalate crystals.

Authors:  T Koide; T Yoshioka; S Yamaguchi; S Hosokawa; M Utsunomiya; T Sonoda
Journal:  Urol Res       Date:  1990

3.  An unidentified macromolecular inhibitory constituent of calcium oxalate crystal growth in human urine.

Authors:  S Sørensen; K Hansen; S Bak; S J Justesen
Journal:  Urol Res       Date:  1990

4.  Effects of the oral administration of glycosaminoglycans on cellular abnormalities associated with idiopathic calcium oxalate nephrolithiasis.

Authors:  B Baggio; G Gambaro; G Marzaro; F Marchini; A Borsatti; G Crepaldi
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

5.  Prophylactic and therapeutic properties of a sodium citrate preparation in the management of calcium oxalate urolithiasis: randomized, placebo-controlled trial.

Authors:  Shameez Allie-Hamdulay; Allen L Rodgers
Journal:  Urol Res       Date:  2005-05-04

6.  Isoelectric focusing of Tamm-Horsfall glycoproteins: a simple tool for recognizing recurrent calcium oxalate renal stone formers.

Authors:  P Schnierle; F Hering; H Seiler
Journal:  Urol Res       Date:  1996

Review 7.  Urinary inhibitors of calcium oxalate crystallization and their potential role in stone formation.

Authors:  R L Ryall
Journal:  World J Urol       Date:  1997       Impact factor: 4.226

8.  Investigation of GAGS on 24-hour and 2-hour urines from calcium oxalate stone formers and healthy subjects.

Authors:  M Gianotti; C Genestar; A Palou; A Pons; A Conte; F Grases
Journal:  Int Urol Nephrol       Date:  1989       Impact factor: 2.370

9.  Acidic polyanion poly(acrylic acid) prevents calcium oxalate crystal deposition.

Authors:  Jack G Kleinman; Laura J Alatalo; Ann M Beshensky; Jeffrey A Wesson
Journal:  Kidney Int       Date:  2008-06-18       Impact factor: 10.612

Review 10.  Genetic basis of renal cellular dysfunction and the formation of kidney stones.

Authors:  Saeed R Khan; Benjamin K Canales
Journal:  Urol Res       Date:  2009-06-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.